Pseudomonas aeruginosa lipopolysaccharide and surface antigens — Drug Target

All drugs that target Pseudomonas aeruginosa lipopolysaccharide and surface antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Polyclonal immunoglobulin Y (IgY) therapeutic

Phase 3 pipeline (1)

• IgY · Mukoviszidose Institut gGmbH · Polyclonal immunoglobulin Y (IgY) therapeutic · Respiratory / Infectious Disease
  IgY is a polyclonal immunoglobulin Y (chicken antibody) therapeutic that targets and neutralizes Pseudomonas aeruginosa virulence factors and biofilm components in the respiratory tract.